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Research
Day­to­day variations in airborne particulate 
matter (PM) associated with air pollution 
have been linked to increases in cardiovascular 
morbidity and mortality (Dockery et al. 1993; 
Pope et al. 1995; Samet et al. 2000; Schwartz 
et al. 1996), especially in individuals who have 
preexisting cardiovascular disease (Dockery 
et al. 2001; Miller et al. 2007; Pope 2000). 
PM exposure likely exacerbates the cardiac 
and vascular pathophysiology attendant to 
hypertension, ischemia, heart failure, dia  betes, 
coronary artery disease, and other dysfunc­
tions of the cardiovascular system. Several 
mechanisms of PM­induced cardiac dysfunc­
tion in humans have been postulated, includ­
ing autonomic modulation, direct effects of 
PM constituents on ion channels, myocardial 
ischemia, and vascular dysfunction related to 
systemic inflammation (Brook et al. 2003; 
Schulz et al. 2005; Utell et al. 2002).
The electrocardiogram (ECG) is an impor­
tant clinical tool that has great prognostic value 
in the assessment of cardio  vascular function. 
Electrocardiographic recordings in humans 
have been used to detect abnormal myo­
cardial impulse conduction, cardiac rhythm 
disturbances, and altered autonomic regu­
lation of heart rate (HR) via the assessment 
of HR variability (HRV). PM exposure has 
been linked to changes in ECG morphology, 
including ST­segment depression (Mills et al. 
2007; Pekkanen et al. 2002), altered T­wave 
amplitude (Henneberger et al. 2005), and QT 
prolongation (Yue et al. 2007). PM exposure 
has also been associated with cardiac rhythm 
changes, including increases in atrial ecto­
pic beats (Sarnat et al. 2006) and ventricu­
lar tachyarrhythmias (Riediker et al. 2004). 
Additionally, fine PM exposures have been 
associated with low HRV, suggesting an inap­
propriate increase in sympathetic tone to the 
heart (Rowan et al. 2007; Zareba et al. 2001). 
Studies in animal models have yielded a simi­
lar spectrum of ECG effects (Campen et al. 
2001; Watkinson et al. 1998; Wellenius et al. 
2002). However, the utility of any or all of 
these electrocardiographic end points as sensi­
tive or reproducible toxicologic indicators for 
targeted pathophysiologic studies of PM and 
its components in rats is unclear.
Recently, Ostro et al. (2007) demon­
strated an association between increased 
cardio  vascular mortality and the fine­PM–
associated metals nickel and iron in ambi­
ent air in nine California counties. Residual 
oil fly ash (ROFA), a waste product of fossil 
fuel combustion from boilers, is rich in the 
transition metals iron, nickel, and vanadium 
(Dreher et al. 1997) and, when released as a 
fugitive particle, is an important contribu­
tor to ambient fine PM air pollution (Ghio 
et al. 2002; Lippmann et al. 2006). Among 
boiler workers, exposure to ROFA deposits 
correlated strongly with nocturnal depres­
sion of HRV, suggesting a significant influ­
ence of transition metals on cardiac function 
(Cavallari et al. 2008). Kodavanti et al. (2000) 
demonstrated that hypertensive rats that inhale 
ROFA develop ST depression during expo­
sure. This sensitivity of hypertensive rats to 
ST depression suggests that they may also be 
susceptible to cardiac arrhythmias and changes 
in HRV. In the present study, we examined 
the effects of a single acute ROFA inhalation 
exposure on ECG morphology, HRV, and 
arrhythmia development in hypertensive and 
normal rats. Our goal in this study was to 
establish a reproducible exposure model in 
sensitive rats to further elucidate the underly­
ing mechanisms of cardiopulmonary responses 
to PM. We used a well­defined and widely 
used PM to dissect the various electrocardia­
graphic lesions induced with a single inhala­
tion challenge.
Materials and Methods
Animals. We obtained adult (12­week­old) 
male Wistar Kyoto (WKY; background strain 
for SH rats) and spontaneously hypertensive 
(SH) rats (SHR/NCrIBR) from Charles River 
Laboratory (Raleigh, NC). Rats were housed 
in plastic cages (one per cage), maintained on 
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Ba c k g r o u n d: Exposure to combustion-derived fine particulate matter (PM) is associated with 
increased cardiovascular morbidity and mortality especially in individuals with cardiovascular 
disease, including hypertension. PM inhalation causes several adverse changes in cardiac function 
that are reflected in the electrocardiogram (ECG), including altered cardiac rhythm, myocardial 
ischemia, and reduced heart rate variability (HRV). The sensitivity and reliability of ECG-derived 
parameters as indicators of the cardiovascular toxicity of PM in rats are unclear. 
oB j e c t i v e: We hypothesized that spontaneously hypertensive (SH) rats are more susceptible to the 
development of PM-induced arrhythmia, altered ECG morphology, and reduced HRV than are 
Wistar Kyoto (WKY) rats, a related strain with normal blood pressure. 
Me t h o d s : We exposed rats once by nose-only inhalation for 4 hr to residual oil fly ash (ROFA), an 
emission source particle rich in transition metals, or to air and then sacrificed them 1 or 48 hr later. 
re s u l t s: ROFA-exposed SH rats developed nonconducted P-wave arrhythmias but no changes in 
ECG morphology or HRV. We found no ECG effects in ROFA-exposed WKY rats. ROFA-exposed 
SH rats also had greater pulmonary injury, neutrophil infiltration, and serum C-reactive protein 
than did ROFA-exposed WKY rats. 
co n c l u s i o n s: These results suggest that cardiac arrhythmias may be an early sensitive indicator of 
the propensity for PM inhalation to modify cardiovascular function.
key  w o r d s : arrhythmia, electrocardiogram, heart rate variability, hypertension, inhala  tion, 
non  conducted P-waves, particulate matter, rats, residual oil fly ash.  Environ Health Perspect 
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a 12/12­hr light/dark cycle at approximately 
22°C and 50% relative humidity in our 
Association for Assessment and Accreditation of 
Laboratory Animal Care–approved facility, and 
held for a minimum of 1 week before implan­
tation. All protocols were approved by the 
Institutional Animal Care and Use Committee 
of the U.S. Environmental Protection Agency. 
Food (Prolab RMH 3000; PMI Nutrition 
International, St. Louis, MO) and water were 
provided ad libitum. The animals were treated 
humanely and with regard for alleviation of suf­
fering. We randomized all rats by weight.
Surgical implantation of telemeters. 
We anesthetized animals (WKY­air, n = 7; 
WKY­ROFA, n = 8; SH­air, n = 8; SH­ROFA, 
n = 8) with an intraperitoneal injection of 
1 mL/kg ketamine­xylazine solution (80 mg/
mL ketamine HCl, 12 mg/mL xylazine 
HCl; Sigma Chemical, St. Louis, MO) and 
implanted them with a bio  potential radio­
telemetry transmitter [model TA11CTA­F40; 
Data Sciences International, Inc. (DSI), St. 
Paul, MN] using aseptic surgical procedures to 
obtain an ECG signal similar to that of lead II 
from the standard ECG and to allow measure­
ment of core body temperature (Watkinson 
et al. 1998). The WKY­air group had one less 
animal because of postsurgical transmitter 
malfunction. We allowed animals 2 weeks for 
recovery from surgery preexposure to ROFA.
Exposure to ROFA. The ROFA used in 
this study (Southern Research Institute, 
Birmingham, AL) was collected as a fugi­
tive stack emission postemission control at a 
Florida Power & Light plant that burned no. 6 
grade residual oil containing 1% sulfur (Hatch 
et al. 1985) and was the same ROFA sample 
used by Kodavanti et al (2000). The compo­
sition of ROFA included vanadium, nickel, 
and iron sulfates and has been previously 
described (Dreher et al. 1997). We selected 
the target concentration (15 mg/m3) for this 
study to mirror that used by Kodavanti et al. 
(2000) in an effort to reproduce the effect of 
ROFA on the ST interval in SH rats, and to 
assess induction of altered HRV and cardiac 
arrhythmia. After 2 days of acclimatization, 
we exposed rats once via nose­only inhalation 
for 4 hr to 13.4 mg/m3 of the PM2.5 fraction 
(mass median aerodynamic diameter, 2.09 µm; 
geometric SD, 3.37) of ROFA or to filtered air 
in two separate 24­port nose­only inhalation 
chambers (Lab Products, Seaford, DE), as pre­
viously described (Ledbetter et al. 1998).
Radiotelemetry data acquisition and analy-
sis. Radiotelemetry allowed continuous moni­
toring and collection of electrocardiographic 
data in unanesthetized rats from implantation 
of the transmitters until sacrifice. We positioned 
receivers (DataART3.01; DSI) beneath home 
cages (when the rats were unrestrained) or 
beneath nose­only inhalation chambers (when 
rats were restrained in tubes) during exposure. 
Sixty second segments of ECG waveforms were 
acquired and saved at 60­min intervals, from 
surgical recovery through euthanasia; values 
were obtained sequentially by animal and rep­
resent averages of 60 sec of data/animal for each 
hour. HR was obtained from the ECG wave­
form. Preexposure data permitted each animal 
to serve as its own control, and animals exposed 
to air provided time­paired control data. We 
obtained preexposure baseline data, that is, one 
1­min segment of the ECG waveform/hour, 
while the animals were unrestrained and in 
their home cages before nose­only inhalation 
exposure. We also obtained preexposure base­
line data at the same sampling rate while the 
rats were in the nose­only restraint just before 
the beginning of exposure. Data were also col­
lected during the nose­only inhalation exposure 
period once/hour for the duration of the 4­hr 
exposure period. The rats were then returned 
to their home cages and postexposure data were 
collected until euthanasia approximately 48 hr 
after the beginning of exposure.
Electrocardiogram. We analyzed each 
signal using e­MOUSE (Boston, MA), an 
Internet­based physiologic waveform analy­
sis portal. e­MOUSE incorporates Fourier 
analyses and linear time­invariant digital fil­
tering of frequencies < 2 Hz and > 100 Hz to 
minimize environmental signal disturbances, 
as previously described (Chu et al. 2001). The 
software uses a peak detection algorithm to 
find the peak of the R­waves and to calculate 
HR. We calculated HRV as the mean of the 
differences between sequential HRs for the 
complete set of ECG signals. The software 
plots its interpretation of P, Q, R, S, and T 
for each beat so that spurious data resulting 
from unfiltered noise or motion artifacts may 
be rejected. It then calculates the means of 
the ECG intervals [i.e., PQ (peak of P­wave 
to beginning of QRS), PR (peak of P­wave to 
peak of QRS), QRS, QT, ST, and RR inter­
vals] for each set of waveforms. The QT inter­
vals were rate corrected (QTc) by application 
of the equation recommended by Mitchell 
et al. (1998) for use in mice and is applicable 
to rats. We used ECGAuto software (EMKA 
Technologies USA, Falls Church, VA) to 
calculate ST­ and T­wave areas. (We calcu­
lated ST area as the area below the isoelectric 
line between the S point of the ECG and the 
beginning of the T­wave, and T­wave area 
as the area above the isoelectric line between 
the beginning of the T­wave and the end of 
the T­wave.) For each 1­min stream of ECG 
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Figure 1. Increased cardiac arrhythmias after ROFA 
inhalation in SH rats. (A) Sample normal and abnor-
mal cardiac rhythms in SH and WKY rats. (B) Total 
nonconducted P-wave arrhythmias during corre-
sponding 24-hr periods pre- and postexposure to 
ROFA or filtered air: mean number of arrhythmias   
± SE (n = 7 or 8). The number of arrhythmias in post-
exposure SH-ROFA rats was significantly greater 
than in preexposure SH-ROFA rats, postexposure 
SH-air rats, and postexposure WKY-ROFA rats.
*p < 0.05.Nonconducted P-waves after PM inhalation in rats
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waveforms, we acquired mean time between 
successive QRS complex peaks (RR interval), 
mean HR, and mean HRV­analysis–generated 
time­domain measures. The time­domain 
measures included standard deviation of 
the time between normal­to­normal beats 
(SDNN), and root mean squared successive 
differences (RMSSD). HRV analysis was also 
conducted in the frequency domain using a 
fast­Fourier transform. The spectral power 
obtained from this transformation represents 
the total harmonic variability for the fre­
quency range being analyzed. In this study, 
we divided the spectrum into low­frequency 
(LF) and high­frequency (HF) regions. The 
ratio of these two frequency domains (LF/
HF) was calculated as an estimate of the rela­
tive balance between sympathetic (LF) and 
vagal (HF) activity. To account for potential 
effects of normal circadian rhythm, we quan­
tified both ECG and HRV parameters for 
time­matched comparisons and compared 
them at different times of the day during the 
preexposure and postexposure periods while 
rats were unrestrained in their home cages. 
We analyzed only some of the total data col­
lected during the monitoring period: morning 
(1000 hr), afternoon (1600 hr), and evening 
(2200 hr). ECG and HRV parameters during 
exposure were analyzed for baseline (record­
ings while in nose­only restraint immediately 
before the beginning of exposure) and for 
hours 1–4 (constituting the entire exposure 
period between 0830 hr and 1230 hr).
ECGAuto software (EMKA Technologies) 
was used to visualize individual ECG signals 
for identification and enumeration of spe­
cific cardiac arrhythmia events. We used the 
Lambeth conventions (Walker et al. 1988) 
as guidelines for the identification of cardiac 
arrhythmic events in rats. Arrhythmias were 
identified as nonconducted P­waves, atrial 
and ventricular premature beats, ventricular 
bigeminy, ventricular couplets, or ventricular 
tachycardia. Figure 1A lists examples of these 
arrhythmias found in the rats used in this 
study. Arrhythmias are generally infrequent, 
and were therefore quantified and totaled over 
a 24­hr period (24 segments of 1 min each) 
preexposure (corresponding to the same times 
assessed postexposure), during the 4­hr expo­
sure period (four segments of 1 min each), or 
during the 24­hr period (24 segments of 1 min 
each) beginning immediately post  exposure.
Necropsy, blood collection, and broncho-
alveolar lavage. We deeply anesthetized rats 
with an intraperitoneal injection of Euthasol 
(200 mg/kg sodium pentobarbital, 25 mg/kg 
phenytoin; Virbac Animal Health, Ft. Worth, 
TX). Blood samples were collected from 
the abdominal aorta and renal artery upon 
exsanguinaton. We cannulated the trachea 
and lavaged the lungs with a total volume of 
35 mL/kg of Ca2+/Mg2+­free, phenol red–free 
Dulbecco’s phosphate­buffered saline (SAFC 
Biosciences, Lenexa, MD) in two equal ali­
quots. Cytospins and cell differentials on bron­
choalveolar lavage (BAL) cell samples; assays for 
total protein (Coomassie Plus protein reagent; 
Pierce, Rockford, IL), albumin (Diasorin, 
Stillwater, MN), lactate dehydrogenase (LDH; 
Thermo DMA, Louisville, CO), and N­acetyl­
β­d­glucosaminidase (Roche Diagnostics, 
Mannheim, Germany) on BAL supernatants; 
and serum C­reactive protein (CRP; kit from 
Diasorin; standard from Kamiya Biomedical 
Co., Seattle, WA) were conducted as previ­
ously described (Farraj et al. 2006).
Histopathology. We immersed each heart 
in a large volume of 10% acetate­buffered 
formalin. After fixation, hearts were trimmed 
and then processed to paraffin blocks, sec­
tioned at a thickness of 5 µm, placed on glass 
slides, and stained with hematoxylin and eosin 
or Barbeito­Lopez trichrome stain for routine 
diagnosis of myocardial degeneration or necro­
sis (Milei and Bolomo 1983). Histopathologic 
changes were assessed by the study pathologist 
(A. Nyska, Sackler Faculty of Medicine, Tel 
Aviv University, Tel Aviv, Israel).
Statistics. We performed statistical analy­
ses for all data in this study using SAS soft­
ware, version 9.1.3 (SAS Institute, Inc., Cary, 
NC). PROC MIXED and PROC GLIMMIX 
procedures were used to analyze all ECG­ and 
HRV­generated data. We used a linear mixed 
model with restricted maximum­likelihood 
estimation analysis (SAS) and least­square 
means post hoc test to determine statistical 
differences for all data. The arrhythmia data, 
however, were not normally distributed, so for 
these we used PROC GENMOD for count 
data using Poisson regression. All arrhythmia 
values had one added to them to prevent zero 
values and to allow model convergence. All 
the biochemical and differential data were 
analyzed using a one­, two­, or three­way 
analysis of variance (ANOVA) model examin­
ing the main effects of each model as well as 
the interactive effects of two­ and three­way 
ANOVA models. We considered p < 0.05 sta­
tistically significant. A significant interaction 
in biochemical or differential data resulted 
in pairwise comparisons performed using 
Tukey’s post hoc test.
Results
HR and HRV. We found no significant dif­
ferences in HR among any of the groups pre­ 
or postexposure (Table 1) or during exposure 
Table 1. HR and HRV pre- and postexposure.
Time  Strain  Exposure  HR (bpm)  SDNN (bpm)  RMSSD (msec)  LF (msec2)  HF (msec2)  LF/HF
Morning baseline (preexposure)  WKY  Air  300.3 ± 12  11.31 ± 1.9  4.07 ± 1.1  7.05 ± 2.9  1.31 ± 0.3  11.93 ± 4.6
    ROFA  313.9 ± 12  16.11 ± 1.9  5.84 ± 1.1  11.49 ± 2.9  1.91 ± 0.3  7.35 ± 4.6
  SH   Air  311.5 ± 13  12.17 ± 2.1  3.29 ± 1.1  8.47 ± 3.1  1.11 ± 0.4  13.82 ± 5.0
    ROFA  287.5 ± 7.0  16.8 ± 3.7  3.58 ± 1.0  9.44 ± 2.7  1.39 ± 0.3  9.24 ± 4.3
Morning (postexposure)   WKY  Air  270.6 ± 7.8  13.09 ± 3.9  6.43 ± 1.1  20.75 ± 7.9  4.74 ± 2.8  5.52 ± 3.1
    ROFA  288.0 ± 8.0  12.79 ± 3.9  5.83 ± 1.1  13.19 ± 7.9  4.54 ± 2.8  4.93 ± 3.1
  SH  Air  273.8 ± 8.4  10.32 ± 4.2  3.65 ± 1.2  7.31 ± 8.6  1.59 ± 3.1  7.06 ± 3.3
    ROFA  287.5 ± 7.3  16.8 ± 3.7  5.17 ± 1.0  22.03 ± 7.4  5.75 ± 2.7  7.34 ± 2.9
Afternoon baseline (preexposure)  WKY  Air  306.6 ± 38  19.57 ± 19  4.03 ± 3.2  9.04 ± 7.7  1.26 ± 16  9.30 ± 3.1
    ROFA  385.7 ± 38  55.6 ± 22  10.50 ± 3.2  18.98 ± 7.7   29.67 ± 16  3.87 ± 3.1
  SH  Air  300.0 ± 41  22.10 ± 24  7.45 ± 3.4  21.97 ± 8.3  20.66 ± 17  10.14 ± 3.3
    ROFA  298.3 ± 36  9.86 ± 20  4.64 ± 0.7  10.70 ± 7.2  1.78 ± 15  6.15 ± 2.9
Afternoon (postexposure)  WKY  Air  281.3 ± 12  16.13 ± 3.4  4.56 ± 0.8  15.95 ± 5.5  2.06 ± 1.3  8.30 ± 5.8
    ROFA  307.6 ± 12  17.93 ± 3.4  4.74 ± 0.8  15.15 ± 5.5  1.82 ± 1.3  10.74 ± 5.7
  SH  Air  305.3 ± 13  12.33 ± 3.6  3.52 ± 0.8  7.66 ± 6.0  1.41 ± 1.4  10.56 ± 6.2
    ROFA  354.4 ± 11  20.15 ± 3.1  4.64 ± 0.7  12.18 ± 5.2  3.42 ± 1.2  15.83 ± 5.4
Evening baseline (preexposure)  WKY  Air  327.1 ± 10  15.80 ± 4.4  5.23 ± 0.7  8.79 ± 12  2.94 ± 1.0  3.28 ± 5.73
    ROFA  344.9 ± 10  17.34 ± 4.4  3.47 ± 0.7  26.64 ± 12  2.25 ± 1.0  12.39 ± 5.7
  SH  Air  319.2 ± 11  14.18 ± 4.7  2.85 ± 0.7  17.77 ± 13  0.72 ± 1.1  21.41 ± 6.2
    ROFA  335.8 ± 13  13.00 ± 4.1  4.44 ± 0.6  11.1 ± 11  2.36 ± 0.9  7.74 ± 5.4
Evening (postexposure)  WKY  Air  333.0 ± 14  12.24 ± 3.5  4.16 ± 2.2  6.37 ± 10  1.63 ± 1.0  4.07 ± 9.9
    ROFA  335.6 ± 14  17.49 ± 3.5  3.66 ± 2.2  19.93 ± 10  1.70 ± 1.0  29.71 ± 9.9
  SH  Air  309.3 ± 15  17.00 ± 3.7  3.51 ± 2.3  25.87 ± 11  1.28 ± 1.1  21.33 ± 11
    ROFA  335.8 ± 13  16.53 ± 3.2  8.06 ± 2.0  19.18 ± 9.4  2.96 ± 0.9  8.5 ± 9.3Farraj et al.
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(data not shown). There were no significant 
differences in SDNN, RMSSD, LF, HF, 
or LF/HF among any of the groups pre­ or   
postexposure (Table 1) or during exposure 
(data not shown).
ECG interval duration and morphology. 
We found no significant differences among 
any of the groups pre­ or postexposure in any 
of the ECG intervals (Table 2; data for PQ 
and ST intervals were not statistically signifi­
cantly different and are not shown) or in ST­ 
and T­wave areas (Table 2).
Cardiac arrhythmia events. Both strains 
of rats had random and infrequent arrhyth­
mias preexposure, including atrial and ven­
tricular premature beats. We observed very 
few instances of bigeminy, ventricular cou­
plets, or ventricular tachycardia in either 
strain pre­ or postexposure. There were very 
few arrhythmias of any type evident during 
the 4­hr exposure period in any of the rats 
(data not shown). ROFA exposure caused 
a 400% increase (p < 0.05) in the episodes 
of nonconducted P­waves in SH rats post­
exposure (24­hr period) compared with the 
number of events in the same rats pre  exposure 
(time­matched; Figure 1B). The ROFA­
induced increase in nonconducted P­waves 
in SH rats was also > 327% than the aver­
age level in air­exposed SH rats postexposure 
(p < 0.05). In addition, the ROFA­induced 
increase in nonconducted P­waves in SH rats 
was > 133% than the average level in WKY 
rats exposed to ROFA postexposure (p < 0.05). 
Most of the nonconducted P­waves took place 
in the first 12 hr postexposure to ROFA in 
the SH rats. Mean postexposure counts 
(± SE) for atrial premature beats were as follows:   
WKY­air, 1.14 ± 0.14; WKY­ROFA, 
2.14 ± 0.40; SH­air, 1.17 ± 0.17; SH­ROFA, 
1.57 ± 0.57. Mean postexposure counts for ven­
tricular premature beats were as follows: WKY­
air, 1.71 ± 0.17; WKY­ROFA,1.43 ± 0.20; 
SH­air, 2.0 ± 0.52; SH­ROFA, 1.86 ± 0.46. 
However, we found no statistically significant 
exposure­ or time­related differences in either 
type of premature beat (p > 0.05).
Inflammatory cell infiltration into the 
lung. ROFA­exposed SH rats had significantly 
greater BAL neutrophils than did air­exposed 
SH rats (6,376% difference; p < 0.05) or 
ROFA­exposed WKY rats (659% difference; 
p < 0.05) 1 hr postexposure (Figure 2A). We 
found no significant difference in BAL neutro­
phils between air­ and ROFA­exposed WKY 
rats, or in BAL macrophages between ROFA­
exposed SH and WKY rats, at 1 hr postexpo­
sure (data not shown). There was no significant 
difference among any of the treatment groups 
in macrophages and neutrophils 48 hr postex­
posure, suggesting that the inflammatory influx 
into the lung may peak soon after exposure.
Markers of injury and edema in lung. 
ROFA­exposed SH rats had significantly 
greater BAL LDH levels than did air­ex­
posed SH rats (211% difference; p < 0.05) or 
ROFA­exposed WKY rats (54% difference; 
p < 0.05) 48 hr postexposure (Figure 2B). 
We found no significant differences in any of 
the exposure groups in BAL LDH levels 1 hr 
postexposure. ROFA exposure did not signifi­
cantly increase BAL LDH levels in WKY rats 
48 hr postexposure.
ROFA­exposed SH rats had significantly 
greater BAL protein levels 1 hr postexposure 
(369% difference; p < 0.05) than did ROFA­
exposed WKY rats (Figure 2C). In addition, 
ROFA­exposed SH rats had significantly 
greater BAL protein levels 48 hr postexpo­
sure than did air­exposed SH rats (186% dif­
ferences; p < 0.05) or ROFA­exposed WKY 
rats (78% difference; p < 0.05) 48 hr post­
exposure. BAL albumin levels were similar to 
protein levels (data not shown).
We found no significant effect of ROFA 
exposure in either strain relative to air controls 
1 hr postexposure in BAL albumin or protein 
levels. Unlike the inflammatory influx, injury 
to the lung required more time to develop.
Serum CRP. SH rats exposed to ROFA 
had significantly higher CRP levels than did 
air­exposed SH rats (18% difference; p < 0.05) 
or ROFA­exposed WKY rats (32% difference; 
p < 0.05) 48 hr postexposure (Figure 2D). We 
found no significant differences among any of 
the treatment groups relative to their respective 
air­exposed controls in serum CRP levels 1 hr 
postexposure. There was no significant differ­
ence between WKY rats exposed to ROFA and 
WKY rats exposed to air 48 hr postexposure. 
Like the markers of injury in the lung, elevation 
in serum CRP required more time to develop 
than did the inflammatory influx into the lung.
Heart weight. Mean heart­to­body 
weight ratios of control rats exposed to 
air 48 hr postexposure were, for WKY, 
3.2 ± 0.2 mg/g, and for SH, 3.53 ± 
0.07 mg/g. Thus, SH rats had a > 10.3% 
heart­to­body weight ratio than did WKY 
rats, which was statistically significant 
(p < 0.05). We found no statistically signifi­
cant effect of ROFA inhalation on heart­to­
body­weight ratios in either strain.
Heart histopathology and temperature. 
There were no PM­exposure–related or strain 
effects on cardiac tissue morphology or body 
temperature (data not shown).
Table 2. ECG interval durations pre- and postexposure.
Time  Strain  Exposure  PR (msec)  QRS (msec)  QTc (msec)  RR (msec)  ST area  T-wave area
Morning baseline (preexposure)  WKY  Air  47.86 ± 1.3  18.23 ± 1.7  71.06 ± 2.2  201.0 ± 7.0  0.51 ± 0.24  0.76 ± 0.25
    ROFA  47.76 ± 1.3  16.73 ± 1.7  70.19 ± 3.0   194.3 ± 7.0  0.38 ± 0.13  1.39 ± 0.41
  SH   Air  45.98 ± 1.4  17.83 ± 1.9  68.50 ± 2.1  195.3 ± 7.0  0.92 ± 0.23  0.64 ± 0.55
    ROFA  44.50 ± 1.2  18.29 ± 1.6  70.89 ± 1.7  209.4 ± 6.4  0.66 ± 0.10  0.43 ± 0.26
Morning (postexposure)   WKY  Air  50.97 ± 1.9  16.97 ± 1.5  70.92 ± 1.8  223.4 ± 6.0  0.64 ± 0.16  0.87 ± 0.33
    ROFA  47.04 ± 1.3  17.56 ± 1.5  71.37 ± 2.5  209.7 ± 6.0  0.40 ± 0.13  1.54 ± 0.46
  SH  Air  45.43 ± 2.0  21.47 ± 1.6  76.94 ± 1.4  221.5 ± 6.5  0.96 ± 0.28  0.64 ± 0.26
    ROFA  46.54 ± 1.8  20.70 ± 1.4  73.63 ± 1.9  209.9 ± 5.6  0.65 ±.0.24  0.95 ± 0.39
Afternoon baseline (preexposure)  WKY  Air  49.31 ± 3.2  19.07 ± 1.5  70.73 ± 2.2  198.4 ± 11  0.36 ± 0.12  0.46 ± 0.11
    ROFA  44.36 ± 3.2  15.86 ± 1.5  65.66 ± 4.0  178.5 ± 11  0.62 ± 0.12  1.12 ± 0.43
  SH  Air  45.67 ± 3.4  17.02 ± 1.7  67.00 ± 1.8  203.5 ± 11  0.69 ± 0.27  1.04 ± 0.48
    ROFA  49.00 ± 3.0  19.61 ± 1.4  68.89 ± 1.4  202.4 ± 10  0.84 ± 0.16  0.41 ± 0.19
Afternoon (postexposure)  WKY  Air  47.39 ± 1.4  18.63 ± 1.5  71.82 ± 2.6  215.2 ± 7.0  0.44 ± 0.11  0.54 ± 0.17
    ROFA  46.16 ± 1.4  17.76 ±1.5  69.11 ± 3.0  197.6 ± 7.0  0.41 ± 0.16  1.70 ± 0.37
  SH  Air  43.68 ± 1.5  18.50 ± 1.6  68.51 ± 2.2  199.0 ± 7.0  0.81 ± 0.16  0.69 ± 0.24
    ROFA  42.98 ± 1.3  17.71 ± 1.4  65.95 ± 1.5  171.2 ± 6.0  0.47 ± 0.11  1.41 ± 0.32
Evening baseline (preexposure)  WKY  Air  46.97 ± 1.1  16.40 ± 1.1  66.57 ± 1.2  184.9 ± 6.1  0.46 ± 0.09  0.70 ± 0.22
    ROFA  45.51 ± 1.1  16.21 ± 1.1  67.07 ± 1.6  176.3 ± 6.1  0.39 ± 0.12  1.72 ± 0.70
  SH  Air  43.37 ± 1.2  18.73 ± 1.2  67.28 ± 1.6  189.7 ± 6.6  1.12 ± 0.21  0.66 ± 0.30
    ROFA  43.95 ± 1.0  18.56 ± 1.0  66.46 ± 1.3  194.8 ± 5.7  0.93 ± 0.21  0.39 ± 0.20
Evening (postexposure)  WKY  Air  45.87 ± 1.4  16.77 ± 1.4  65.05 ± 2.1  182.7 ± 7.3  0.43 ± 0.09  0.47 ± 0.18
    ROFA  41.67 ± 1.4  15.39 ± 1.4  67.31 ± 2.7  181.1 ± 7.3  0.43 ± 0.09  1.28 ± 0.49
  SH  Air  44.68 ± 1.5  19.75 ± 1.5  70.62 ± 2.1  195.6 ± 7.9  0.80 ± 0.24  1.08 ± 0.23
    ROFA  44.08 ± 1.3  19.06 ± 1.3  69.11 ± 2.9  181.7 ± 6.9  0.71 ± 0.16  1.02 ± 0.42Nonconducted P-waves after PM inhalation in rats
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Discussion
In the present study, cardiac arrhythmias 
were more sensitive indicators of the effects of 
acute oil fly ash inhalation than were changes 
in ECG morphology and HRV in hyper­
tensive rats. ROFA inhalation increased the 
frequency of nonconducted P­waves in hyper­
tensive but not in normal rats during the first 
24 hr postexposure. Most of these arrhythmic 
events occurred during the first 12 hr after 
ROFA exposure. The non  conducted P­waves 
in the ROFA­exposed SH rats in this study 
were preceded by unchanging PR intervals, 
and thus were similar to Mobitz type II sec­
ond­degree atrioventricular block observed 
in humans, which is usually associated with 
a lesion in the bundle branch conduction 
pathway (Scheidt 1986). It is unclear, how­
ever, whether such lesions exist in rats and 
whether a single ROFA exposure would be 
sufficient to elicit such injury. Additionally, 
the role of autonomic, electrolyte, or other 
influences in the generation of these car­
diac events is uncertain, so the etiology of 
the nonconducted P­waves that were pres­
ent in ROFA­exposed SH rats needs to be 
further studied. Nevertheless, these abnormal 
rat rhythms are in line with multiple stud­
ies that have linked fine PM exposure with 
the development of cardiac arrhythmias. Fine 
PM exposure has also been associated with 
increases in ventricular and supra  ventricular 
tachycardia in patients with coronary heart 
disease (Berger et al. 2006; Dockery et al. 
2005), atrial premature beats in patrol officers 
(Riediker et al. 2004), and atrial and ven­
tricular ectopy in elderly subjects (Sarnat et al. 
2006). Analogously, ROFA or its transition 
metals have been linked to the development 
of cardiac arrhythmia in rats (Campen et al. 
2001; Watkinson et al. 1998; Wellenius et al. 
2002). Collectively, these studies suggest that 
cardiac arrhythmias may be sensitive and 
quantifiable indicators of the cardiovascular 
effects of PM in susceptible individuals.
ROFA exposure in both strains of rats 
failed to cause a decrement in HRV, suggest­
ing that HRV parameters are not as sensitive 
as cardiac arrhythmias to the effects of acute 
ROFA inhalation in this model. HRV is the 
degree of difference in the interbeat intervals 
of successive heartbeats and is an indicator 
of the balance between the sympathetic and 
parasympathetic arms of the autonomic ner­
vous system (Rowan et al. 2007). Low HRV, 
reflecting inappropriately increased sympa­
thetic tone (Rowan et al. 2007), is associated 
with an increased risk of cardiac arrhythmia 
(Corey et al. 2006) and an increased mortality 
rate in people with heart disease (Bigger et al. 
1993; Fauchier et al. 2004). An association 
between high ambient PM and low HRV has 
been observed in several different studies in 
both healthy and diseased individuals (Chuang 
et al. 2005; Muggenburg et al. 2000; Schulz 
et al. 2005; Vallejo et al. 2006). Other inves­
tigators, however, have reported increases in 
HRV with exposure to vanadium in ambient 
PM (Magari et al. 2002) and fine PM mass 
itself (Timonen et al. 2006). The data in this 
study and others suggest that the effects of PM 
pollution on HRV and the prognostic value of 
HRV in air pollution studies are uncertain.
ROFA exposure in both strains of rats 
failed to cause any changes in ECG interval 
duration, including RR and QT intervals, sug­
gesting that such end points may not be sensi­
tive to acute PM exposure in this model of 
hypertension. In addition to interval time, the 
morphology of the ECG waveform can also 
provide information about cardiac physiol­
ogy. Air pollution exposure has been associ­
ated with changes in ventricular repolarization 
as indicated by altered T­wave morphology, 
or T­wave alternans, in patients with isch­
emic heart disease (Henneberger et al. 2005). 
Changes in repolarization may trigger arrhyth­
mogenesis and thus have been used to identify 
patients at risk for cardiac death (Henneberger 
et al. 2005). The ST segment of the ECG is 
most sensitive to drugs or disease (DSI 2002), 
and ST depression is temporally associated with 
myocardial ischemia (Scheidt 1986). Ischemic 
episodes are negative prognostic indicators that 
point to an increase in the probability of future 
cardiac events, including myocardial infarction 
(Tzivoni et al. 1988). Traffic­related PM has 
been linked with ST­segment depression in 
elderly patients (Gold et al. 2005) and patients 
with coronary heart disease (Pekkanen et al. 
2002). Kodavanti et al. (2000) performed a 
qualitative assessment of ECG signals derived 
from SH rats and found that ROFA caused 
an ST depression during the first two of three 
inhalation exposures (Kodavanti et al. 2000). 
Rats lack an equivalent human ST­segment 
because of the fast rate at which their ven­
tricular myocytes repolarize (DSI 2002). 
Notwithstanding this difference, perturbations 
that result in ST­segment changes in species 
with ST segments produce a similar shift in the 
corresponding portion of the ECG in rats (DSI 
2002). In our study, we found no significant 
differences in ST­ or T­wave areas among any 
of the exposure groups or strains, suggesting no 
evidence of ST depression or altered ventricu­
lar repolarization. The inability to clearly repro­
duce the findings of Kodavanti et al. (2000) 
may be related to subtle differences between 
the studies (duration or concentration). On the 
other hand, these findings suggest that such a 
change may not be consistent because of con­
founders affecting sensitivity to challenge at 
rest. An analysis of ST­segment changes may 
be more appropriate when HR is elevated, as 
in exercise (as found in humans; Pekkanen 
et al. 2002; Mills et al. 2007), because oxygen 
demand is elevated, thus increasing the likeli­
hood of ischemic episodes, which in turn may 
be reflected in ST changes in the ECG (Scheidt 
1986). Such tests may be adaptable to animal 
bioassays to better assess the effects of PM or 
other pollutants on cardiac ischemic changes or 
changes in repolarization reflected in the ECG.
The inhalation of fine PM has been linked 
to both pulmonary and systemic inflammation 
(Brook et al. 2003; Utell et al. 2002), includ­
ing increases in the circulating acute­phase 
Figure 2. Greater inflammatory response in SH rats after ROFA inhalation. Inflammatory markers in BAL 
fluid and serum 1 or 48 hr postexposure to ROFA or filtered air. (A) BAL neutrophils. (B) BAL LDH. (C) BAL 
protein. (D) Serum CRP. Values represent mean ± SE (n = 7 or 8). 
*p < 0.05 compared with SH-air and WKY-ROFA rats.
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marker CRP and increases in indicators of 
endothelial dysfunction and injury in the cir­
culation (Calderon­Garciduenas et al. 2008). 
Episodes of cardiac dysfunction, including 
cardiac arrhythmias, may result from sys­
temic inflammation via altered coagulative 
processes, destabilization of arterial plaques, 
and/or exacerbation of atherosclerotic plaque 
formation (Brook et al. 2003). Elevated CRP 
paralleling ECG changes, including QT pro­
longation and decreased T­wave amplitude, 
has also been reported in coronary artery dis­
ease patients exposed to ambient fine PM (Yue 
et al. 2007). Furthermore, systemic inflamma­
tion may actually trigger cardiac arrhythmia as 
evidenced by the finding that elevated serum 
CRP was predictive of the recurrence rate 
of atrial fibrillation, another type of cardiac 
arrhythmia (Hatzinikolaou­Kotsakou et al. 
2006). SH rats exposed to ROFA in the pres­
ent study had significantly higher pulmonary 
influx of neutrophils, markers of pulmonary 
edema and injury, including LDH, protein, 
and albumin, and higher serum CRP levels 
than did similarly exposed WKY rats with nor­
mal blood pressure; these pulmonary responses 
were quite similar to the findings of Kodavanti 
et al. (2000) after three exposures. The strong, 
strain­dependent inflammatory response in 
SH rats exposed to ROFA in this study may 
have contributed to the development of the 
nonconducted P­wave arrhythmias.
The incidence of nonconducted P­wave 
arrhythmias increased only in SH rats exposed 
to ROFA, suggesting that hypertension con­
ditions the heart, creating a substrate that 
increases the susceptibility to PM­induced 
arrhythmia. Although we did not measure 
blood pressure in this study, SH rats have sig­
nificantly higher mean arterial pressure relative 
to their related background strain, the WKY 
rats (Yamori et al. 1979). Hypertension over 
time leads to hypertrophy of the left ventricle 
(American Heart Association 2008), a condi­
tion present in the SH rats of this study as 
evidenced by their higher heart­to­body weight 
ratio compared with WKY rats. Several remod­
eling events take place in the hypertrophying 
heart that may heighten myocardial sensitivity 
to the effects of PM exposure, including a) pro­
longed QT intervals and action potential 
duration resulting from changes in calcium 
ion channel density, b) aberrant expression 
of proteins/currents specific to the sinoatrial 
node, suggesting that the ventricles can acquire 
automaticity, and c) an increase in the den­
sity of connexin 40 (a gap­junction protein 
involved in cell­to­cell electrical coupling), 
which is usually confined to the atria and has 
greater conductance (Swynghedauw 1999). 
That SH rats undergo left ventricular hypertro­
phy is well documented (Yamori et al. 1979), 
suggesting that the SH rats in this study may 
have undergone some of these remodeling 
events during the course of disease progres­
sion that predisposed them to the develop­
ment of ROFA­induced nonconducted P­wave 
arrhythmias. The absence of any clear histo­
logic distinction between SH and WKY rat 
hearts in this study suggests that the differences 
may be at the ultrastructural and molecular 
levels. Nevertheless, these findings clearly point 
to a compromising effect of hypertension on 
the responsiveness to ROFA in SH rats.
In summary, compared with HRV and 
ECG morphology in this rat model of hyper­
tension, cardiac arrhythmias, particularly non­
conducted P­waves, were the most sensitive 
indicators of the adverse cardiovascular effects 
of ROFA inhalation, suggesting that cardiac 
arrhythmias may have predictive value in the 
assessments of the effects of air pollution. This 
model may in turn be used to compare the 
capacity of other PM samples to elicit cardiac 
arrhythmias in the context of hypertension, 
potentially facilitating comparisons of the 
cardiovascular toxicity of PM from different 
air sheds. In addition, PM­induced cardiac 
arrhythmias found in this model may help elu­
cidate the mechanism of action. One additional 
mechanism that requires further study involves 
direct injury to cardiac myocytes resulting from 
the translocation of metals to the heart after 
inhalation. ROFA metals, including nickel and 
vanadium, leach into the blood from the lung 
and enter other organs, including the heart 
(Wallenborn et al. 2007), and thus may have 
had a direct role in the development of noncon­
ducted P­wave arrhythmias in this study. This 
study also demonstrated that normal animals 
have very minimal responses to very high acute 
PM exposure, with only a mild inflammatory 
response and no evidence of cardiac arrhythmia. 
Healthy humans or animals may thus be more 
resistant to the effects of air pollution compared 
with diseased cohorts, suggesting that the effects 
of air pollution should more appropriately be 
assessed in the context of preexisting disease. 
Factors that may influence the sensitivity of 
ECG end points that we did not address in this 
study include repeated or chronic exposures to 
ROFA, exposure to lower concentrations of 
ROFA, exposure to other PM samples, or the 
exposure of animals with other cardiovascular 
diseases. Taken together, the data suggest, how­
ever, that cardiac arrhythmia may be an early 
sensitive ECG indicator of the propensity for 
PM inhalation to modify cardiovascular func­
tion and trigger acute cardiac events.
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